The RSI is a valuable technical indicator that measures the strength and momentum of a stock's price movement. Ranging from 0 to 100, an RS...

While the stock has failed to hold its record high and is considered to be overbought, it's still viewed as a profitable investment as it h...

“The Pharma Index is now trading above its 50-day moving average, indicating that buying interest is likely to continue in the short term.”

Reliance Industries wil host its 45th post IPO annual general meeting on Monday. The traders be keenly looking an update from its chairman ...

The brokerage believes that weakness in China's export prices will dent the company, leading to an EBITDA cut by 32-34 per cent on the back...

On a standalone basis, the company’s quarterly net profit stood at Rs 147 crore in March 2022, down 8.41 per cent from Rs 160.50 crore in M...

The four shortlisted stocks have a minimum upside potential of 10%.

Equity investors were left poorer by Rs 1.06 lakh crore by the end of the day. Stocks from sectors, barring some IT names, saw selling. Ban...

Mazhar Mohammad of Chartviewindia.in said Nifty breaking out of the consolidation phase suggests the index is now eyeing the 16,300 level.

Banking and NBFCs, cement or even auto ancillary stocks from broader market to take the market higher, says Hemang Jani

Here are top stocks and sectors that created all the buzz during the week gone by.

Nifty futures on the Singapore Exchange traded 80.85 points or 0.88 per cent lower at 9,148.25, indicating a negative start for Dalal Stree...

The BSE Sensex surged 266 points, or 0.93 per cent, to settle at 28,773. The Nifty50 could not kiss the 8,900 mark, but managed to climb 1....

InterGlobe last week lost 19% of its market value in a single day on concerns over increased competition, rising input cost and delay in ai...

The silver lining has really been retail investors, who showed huge interest on the PathLabs issue by oversubscribing the quota.

The domestic equity market has had a rather lacklustre year, but the IPO market seems ready to sign off an eventful year with a bang.

Biocon has gained nearly 9 per cent in the past six months, compared to a 2 per cent fall in the BSE benchmark Sensex.